Abstract
Bacteriophages are viruses that attack bacterial cells, resulting in their lysis. Since the emergence of antibiotic resistance, phages have gained attention from the scientific community and are being explored for their potential use as anti-microbial agents. Since their discovery, naturally occurring wild-type phages have been used as anti-microbial agents. Though usage of antibiotics is confronted with problems, antibiotic resistance being the most pronounced, phages also have limitations, such as harboring toxin genes, not always lytic in nature, being involved in transduction, not having a broad host range, having a short life in the body due to mammalian immune response, and being attacked by bacterial anti-phage defense mechanisms. Modern approaches to phage therapy can address these problems associated with conventional phage therapy. These modern approaches include genetic phage engineering and using phage-derived enzymes, such as depolymerases and endolysins, in their wild-type form as well as in genetically engineered form. Genetic engineering has been performed on lytic, lysogenic, and filamentous phages for desired targeted results. In this review, we discuss the previous studies that have investigated these modern approaches for phage therapy against bacterial infections. Advantages and disadvantages of phage therapy are being discussed, and it is discussed how the use of modern approaches can affect different aspects of phage therapy.

This publication has 150 references indexed in Scilit: